跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML - PPB Drug Approval Details
Approvals
/
PPB
/
JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML
Approved
STANDARD
JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML
GLAXOSMITHKLINE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
6298263d7b2dbf46
Company
GLAXOSMITHKLINE LIMITED
Type
Standard
Approval Details
Approval Id
6298263d7b2dbf46
Product Name
JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML
Drug Hk Name
JEMPERLI CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/10ML
Registration Code
HK-67364
Company Name
GLAXOSMITHKLINE LIMITED
Company Detail Path
/organization/glaxosmithkline
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2022-02-23
Company Address
FLAT/RM 04-10, 10/F, TOWER 6, THE GATEWAY, 9 CANTON ROAD, TSIM SHA TSUI, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
6298263d7b2dbf46
Type
Standard
Back to PPB Approvals